NATO Support and Procurement Agency #26LBS036

Procurement of Pyridostigmine Bromide Tablets 30mg for Human Use

This opportunity is issued by the NATO Support and Procurement Agency (NSPA), LB - General and Cooperative Services Programme, for the supply of Pyridostigmine Bromide tablets 30mg for human use. - Government Buyer: - NATO Support and Procurement Agency (NSPA) - LB - General and Cooperative Services Programme - Product Requested: - Pyridostigmine Bromide tablets 30mg - NATO Stock Number: 6505-14-441-1602 - Estimated total quantity: over 147,000 units (BX30) over five years - OEMs and Vendors: - No specific OEMs or vendors named in the notice - Unique/Notable Requirements: - Suppliers must have ISO 9001 certification - Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) required - Marketing Authorization by a Stringent Regulatory Authority (if available) - Manufacturers must negotiate user rights and access to the Technical Data Package with the original equipment manufacturer - Only suppliers from NATO countries, Austria, and Ukraine are eligible to participate

Description

This opportunity is for the supply of Pyridostigmine Bromide tablets 30mg intended for human use. The procurement aims to establish an Outline Agreement for 5 years with an estimated quantity of over 147,000 units (BX30) over this period. Quality assurance requirements include ISO 9001, Marketing Authorization by a Stringent Regulatory Authority if available, Good Manufacturing Practices, and Good Distribution Practices. Interested manufacturers must negotiate user rights and access to the Technical Data Package with the original equipment manufacturer. The tentative RFP date is June 15, 2026, and the publication date is May 6, 2026.

View original listing